Medication Adherence

AARDEX Group

Prescribing the Future of Medication Adherence Monitoring

AARDEX Group was initially established in 1984 in Fremont, California by Professor John Urquhart. Since then, AARDEX Group has been at the forefront of medication adherence technology, creating the first ever ground-breaking Medication Event Monitoring System, MEMS®. MEMS has been instrumental in accurately depicting, quantifying, and enhancing patient adherence behaviours in over 1,000 clinical trials its launch.

DCT

ESMS

ESMS provides specialist services to support Clinical Trials and Medical Information. ESMS is  available to cover  Medical Monitoring and emergency unblinding requirements 24 hours a day and 7 days a week, wherever you are in the world.

ESMS’s global reach means we currently support more than 300 studies and 110K patients in 80 countries, speaking over 45 different languages.

DCT

Kayentis

Kayentis, a global leader in eCOA and Decentralised Clinical Trial solutions, empowers pharma, biotech, and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency, and data quality.

Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in diverse therapeutic areas. Adapting to the changing landscape, Kayentis now offers a comprehensive suite of services to support the shift towards decentralised and hybrid trials, with offices in the US (Boston), France (Grenoble), and Japan (Tokyo).

Drug Management/Optimisation

N-SIDE

N-SIDE makes clinical supply planning efficient with optimisation technology and services.

“Through integrations and Almac’s capacity to implement N-SIDE’s optimal recommendations, we have been able to significantly reduce drug waste and risks of shortages on countless trials in the past decade”.

DCT

Thread

Focused on Patients to Gather Quality Evidence that Matters Most to Them

Offering comprehensive value to our customers by enabling them to design, operate and scale patient first research. Through our unique combination of scientific expertise, operational experience, and research technology platform, we provide sponsors and CROs fit-for-purpose solutions that matter to patients and sites.

“A decentralized trial model brings many opportunities to harness best-in-class technologies in order to reduce burden on sponsors, CROs, sites and participants.  THREAD are excited to be working with Almac to simplify and streamline operations for sites, sponsors and CROs in order to improve trial conduct.”

Joss Warren, VP, Strategic Accounts

EDC

Veeva

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging Biotechs.

As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

EDC

Zelta

Zelta is a cloud-based unified clinical data management and acquisition platform with adaptable modules that can be tailored to meet the unique needs of your clinical trials program and accelerate outcomes. Built on a single codebase that includes EDC, RTSM, Medical Coding with AI, eCOA, eConsent, Local Labs, eLearning, and reporting offered with a delivery model enabling clients to build and manage studies on their own while supporting integration with other platforms in the clinical trial ecosystem.